*
Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice
54321
Identify appropriate patients to refer for a genetic cancer risk assessment (GCRA).
Explain the GCRA process and recognize the changing landscape of genetic testing – syndrome-driven versus multi-gene panels.
Summarize the benefits and limitations of surveillance and risk management options for cancer predisposition syndrome.
*
Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor
54321
Course content.
Arelis E. Martir-Negron, M.D., FACMG
*
*
*
*
*